The EluNIR
Ridaforolimus
drug-eluting
everolimus
sirolimus
stents
zotarolimus
Journal
Expert review of medical devices
ISSN: 1745-2422
Titre abrégé: Expert Rev Med Devices
Pays: England
ID NLM: 101230445
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
pubmed:
20
11
2018
medline:
8
6
2019
entrez:
20
11
2018
Statut:
ppublish
Résumé
First-generation drug-eluting stents (DES) were developed and indeed proved their superiority compared to bare-metal stent in minimizing neo-intimal hyperplasia and in-stent restenosis (ISR), overall, reducing target vessel revascularization (TVR). Newer-generation DES are characterized by thinner struts, more biocompatible and either durable, biodegradable or polymer-free surfaces, better device profile and refined drug elution. Area covered: The EluNIR
Identifiants
pubmed: 30452290
doi: 10.1080/17434440.2018.1549986
doi:
Substances chimiques
ridaforolimus
48Z35KB15K
Sirolimus
W36ZG6FT64
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM